Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging in Diagnosis and Staging of Lung Cancer
PDF

Review

Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging in Diagnosis and Staging of Lung Cancer

Nucl Med Semin 2018;4(1):6-17 DOI: 10.4274/nts.2018.002
,
PDF
Permissions

Abstract

Positron emission tomography/computed tomography (PET/CT) using fluorine-18 labelled fluorodeoxyglucose (FDG) is a powerful tool for managing patients with suspected lung nodules and lung cancer. In this review, we discuss the utility of FDG PET/CT imaging in evaluation of suspected pulmonary nodules and initial staging of patients with newly diagnosed lung cancer, prognostic value of quantitative PET parameters, technical developments in PET imaging such as hybrid PET/magnetic resonance systems, and the use of other PET radiopharmaceuticals related to lung cancer pathophysiology.

Keywords: Lung cancer, non-small cell lung cancer, small cell lung cancer, FDG, PET/CT imaging